Imagine three startups, each tackling a different slice of the tech pie—AI‑driven health, decentralized finance, and automated risk mitigation—suddenly finding themselves flush with fresh capital. The buzz isn’t just about the money; it’s about the strategic signals these deals send to the broader ecosystem. In this post we unpack the recent funding rounds for Euno, Harmoni, and ZeroRisk, why investors are betting big, and what the next chapter could look like for the industry.
What's Going On
The latest wave of venture activity was highlighted in a concise roundup that detailed the exact numbers, lead investors, and strategic rationales behind each deal. According to VC funding deals: Euno, Harmoni, ZeroRis, Euno secured $120 million, Harmoni attracted $85 million, and ZeroRisk closed a $70 million round.
Euno, a Berlin‑based AI platform, is building a next‑generation health‑data engine that promises real‑time diagnostics for chronic diseases. Harmoni, headquartered in Singapore, focuses on a cross‑border payments network that leverages blockchain to cut settlement times to seconds. ZeroRisk, an Austin startup, offers a SaaS solution that uses machine learning to predict and prevent operational losses for mid‑size enterprises.
The investors behind these rounds are a blend of legacy VC firms and corporate strategic arms. Notable names include Sequoia Capital, Accel, and a new venture arm of a major insurance carrier that sees ZeroRisk as a direct line to its underwriting division. The convergence of deep tech and sector‑specific expertise is a pattern that’s becoming increasingly common in 2026.
Why This Matters
Beyond the headline numbers, the deals illustrate a broader shift in where capital is flowing. Industry observers point out that the appetite for AI‑centric solutions is no longer limited to pure‑play AI startups. As 15 great press release examples (plus ti notes, the integration of AI into regulated domains—healthcare, finance, and risk management—offers a higher barrier to entry and, consequently, higher upside for early investors.
For the startup ecosystem, this translates into more rigorous due diligence, stronger emphasis on data compliance, and a premium placed on teams that can navigate both technology and industry regulations. The funding also signals confidence that these verticals are ready for scale, which could accelerate product roll‑outs, hiring sprees, and international expansion plans.
Stakeholders across the board feel the ripple. Large enterprises gain early access to cutting‑edge tools without having to build them from scratch. Regulators see a chance to work with well‑funded innovators who can afford robust compliance frameworks. And, of course, the talent pool gets a clearer picture of where the next high‑impact careers will emerge.
What It Means for the Industry
Analyzing the three deals together reveals a strategic alignment that goes beyond capital. Euno’s focus on AI‑powered health diagnostics dovetails with the growing demand for remote patient monitoring, a trend accelerated by post‑pandemic telehealth adoption. Harmoni’s blockchain‑based payments infrastructure tackles the persistent friction in cross‑border transactions, positioning it to benefit from the rise of digital commerce in emerging markets.
ZeroRisk’s machine‑learning risk engine is perhaps the most intriguing, as it directly addresses a pain point that many midsize firms have struggled with: the inability to predict operational loss events before they happen. By embedding predictive analytics into everyday workflows, ZeroRisk could become a de‑facto standard for risk‑aware enterprises.
Strategically, the presence of a corporate insurance venture in ZeroRisk’s round suggests a future where insurers partner with—or even acquire—tech firms to modernize underwriting. This could reshape the traditional insurance value chain, pushing it toward a more data‑driven, preventative model.
To round out the picture, the recent VC funding deals: Konko AI, HiddenLayer, report shows a parallel surge in AI infrastructure funding, reinforcing the notion that the ecosystem is building a layered stack: foundational AI tools, domain‑specific applications, and finally, risk‑management overlays.
What Happens Next
The next few months will be a litmus test for how quickly these startups can translate capital into market traction. According to Inside Europe's bid to compete in space, the broader tech landscape is entering a phase where cross‑border collaboration becomes a competitive advantage, mirroring the very problem Harmoni aims to solve.
For Euno, the roadmap includes FDA‑type approvals for its diagnostic modules in the EU and North America, a process that could take 12‑18 months but would unlock massive payer contracts. Harmoni is already piloting its network with two major Asian banks, and a successful rollout could see it become the default layer for regional remittances. ZeroRisk plans to integrate its platform with ERP systems from the top three enterprise software vendors, a move that could embed its risk engine into the daily operations of thousands of companies.
Investors will be watching key metrics: user adoption rates, regulatory milestones, and partnership depth. The startups that can demonstrate measurable impact—reduced hospital readmission rates for Euno, lower transaction fees for Harmoni, and a quantifiable drop in loss events for ZeroRisk—will likely attract follow‑on rounds, potentially pushing valuations into the unicorn tier.
In the meantime, the broader venture community is taking notes. The blend of deep tech, sector expertise, and strategic corporate involvement is shaping a new playbook for funding rounds that aim to solve real‑world problems at scale. As the ecosystem evolves, we can expect more “smart money” moves that not only fund but also actively shape product direction, regulatory navigation, and go‑to‑market strategies.
